

1.6K
Downloads
31
Episodes
Odds & ENDS is an educational podcast series created by the VISN 1 Tobacco Treatment Program to help keep clinicians informed on electronic nicotine delivery systems (ENDS). The series covers the latest research and clinical recommendations on e-cigarettes, vaping, and other emerging nicotine products. Episodes provide overviews of ENDS components, regulations, prevalence, health risks, and considerations for tobacco cessation. The goal of this series is to prepare VA healthcare providers to address patient questions and offer guidance for evidence-based decision making on these rapidly evolving products. Continuing education is provided for VA employees in partnership with VA Northeast Consortia (VANEC) for VISNs 1, 2, 4, 5.
Episodes

Jan 31, 2025
Jan 31, 2025
19 min
Tune in to learn about ENDS use among individuals with mental health and substance use diagnoses. We discuss research showing a correlation between mental health conditions like depression and anxiety and ENDS use, the potential bi-directionality of these relationships, and how perceptions of ENDS as less harmful may contribute to their use among those with mental health or substance use diagnoses.
Click here to download the episode handout.

Jan 31, 2025
Jan 31, 2025
17 min
We discuss ENDS use among pregnant women and older adults, focusing on the prevalence and potential fetal health impacts. Research indicates that ENDS use among pregnant women could potentially impact fetal health due to nicotine and other toxicants, while in older adults, ENDS are primarily used as an alternative to smoking, with mixed evidence on their implications for respiratory and cardiovascular health.
Click here to download the episode handout.

Jan 31, 2025
Jan 31, 2025
17 min
We discuss ENDS use among pregnant women and older adults, focusing on the prevalence and potential fetal health impacts. Research indicates that ENDS use among pregnant women could potentially impact fetal health due to nicotine and other toxicants, while in older adults, ENDS are primarily used as an alternative to smoking, with mixed evidence on their implications for respiratory and cardiovascular health.
Click here to download the episode handout.

Jan 31, 2025
Jan 31, 2025
15 min
Delve into the use of ENDS among young adults, including the high prevalence of usage in this demographic, factors that contribute to their use, such as marketing strategies and the appeal of flavors, as well as the potential health risks and downstream effects of ENDS use in young adults.
Click here to download the episode handout.

Jan 31, 2025
Jan 31, 2025
15 min
Delve into the use of ENDS among young adults, including the high prevalence of usage in this demographic, factors that contribute to their use, such as marketing strategies and the appeal of flavors, as well as the potential health risks and downstream effects of ENDS use in young adults.
Click here to download the episode handout.

Jan 31, 2025
Jan 31, 2025
18 min
Tune in to hear about the potential risks and harms associated with nicotine and other components of ENDS. We will also discuss the serious risks of injury from ENDS devices and overdose from nicotine.
Click here to download the episode handout.

Jan 31, 2025
Jan 31, 2025
18 min
Tune in to hear about the potential risks and harms associated with nicotine and other components of ENDS. We will also discuss the serious risks of injury from ENDS devices and overdose from nicotine.
Click here to download the episode handout.

Jan 31, 2025
Jan 31, 2025
11 min
This episode introduces Modern Oral Nicotine Pouches (MOPs), another emerging product. We describe MOPs, raise questions on their potential as a smoking cessation aid while also cautioning about the unknown health risks and the need for more comprehensive studies to understand their long-term safety and efficacy for patients.
Click here to download the episode handout.

Odds & ENDS
Acknowledgements: Odds & ENDS with Dr. Jonathan K. Lee and Dr. Ariel Laudermith is brought to you by VISN 1 Tobacco Treatment through a grant awarded by Pfizer. Research and science writing by Dr. Kerry Kinney. We thank Dr. Alexandria Lindvig-Springborn and Dr. Sophie Schuyler for their input on the development and conceptualization of this learning series. We extend our heartfelt gratitude to our producer, Patrick Kirby. We thank the team at Billerica Access TV, whose facilities and team were crucial in hosting and helping us piece together this learning series. Continuing education and marketing is made possible through support of Cathy Tenerowicz, MBA and Keith Ortiz from VISN 1 Education, and Jason Trojnar from VA Northeast Consortia (VANEC). Design by BELdesigns. Music Cool Revenge by Jeremy Blake.